AI-generated analysis. Always verify with the original filing.
Crinetics Pharmaceuticals, Inc. disclosed that Jeff Knight resigned as Chief Development and Operating Officer, effective on or about April 10, 2026, after notifying the company on March 17, 2026. The resignation is to pursue another opportunity with no disagreement on operations, policies, or practices, and his responsibilities will be reassigned to the executive leadership team.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors, Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 17,
Jeff Knight
Effective: 2026-04-10
to pursue another opportunity, not related to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices